Clinico-haematological profiling of transfusion dependent and non transfucion dependent beta thalassaemia syndrome in Kedah

Introduction: β thalassaemia is a group of haemoglobin diseases caused by a reduction or absence in the synthesis of β globin chains. Affected individuals can be heterozygous, compound heterozygous, or homozygous for β thalassaemia, or even have interactions with other haemoglobinopathies. Kedah has...

Full description

Saved in:

Bibliographic Details
Main Author:	Azizi, Fahmaa
Format:	Thesis
Language:	English
Published:	2020
Subjects:	R Medicine
Online Access:	http://eprints.usm.my/49359/1/Fahmaa%20Azizi-24%20pages.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

id	my-usm-ep.49359
record_format	uketd_dc
spelling	my-usm-ep.493592021-06-27T15:22:10Z Clinico-haematological profiling of transfusion dependent and non transfucion dependent beta thalassaemia syndrome in Kedah 2020 Azizi, Fahmaa R Medicine Introduction: β thalassaemia is a group of haemoglobin diseases caused by a reduction or absence in the synthesis of β globin chains. Affected individuals can be heterozygous, compound heterozygous, or homozygous for β thalassaemia, or even have interactions with other haemoglobinopathies. Kedah has a high prevalence of thalassaemia patients with 20.25/100000 populations. Different mutations have been identified in the β globin (HBB) gene generating diverse clinical phenotypes in β thalassaemia. The identification of the genotype is important for proper counselling to patients and their families. Objectives: To determine the clinical, haematology and β mutation profiling of β thalassaemia patients in Kedah. Methods: 100 patients with β thalassaemia were traced through hospital information system. A detailed clinical and laboratory records of patients were retrieved. For β thalassaemia genotyping, 20 different mutations were tested by MARMS technique. Result and Discussions: Out of 100 patients, 66% were transfusion dependent (TDT) and 34% of the studied patients were non transfusion dependent (NTDT). In this study the TDT patients had significantly lower mean age of diagnosis with 2.75 (2.28) years as compared to 19.87(17.87) years in NTDT (p <0.001). There was statistically significant presence of short stature and a larger mean size of spleen in patients with TDT as compared to NTDT. The significant differences between haematological parameters in both groups of patient were well observed in this study. Both NTDT and TDT group of patients were among compound heterozygous Hb E/ β thalassaemia with 85.3% and 75.8% respectively. In TDT patients, the commonest mutations observed was CD26(G>A)/IVS1-5(G>C) (28.8%), followed with CD26(G>A)/IVS1-1(G>T) (13.6%) and CD26(G>A)/CD41/42(-TTCT) (13.6%). In the NTDT group, the common mutations observed were IVS1-1(G>T) and CD19 trans to Hb E (CD26 (G>A) with 32.4% and 29.4%, respectively. It was noted in this study, diversity of phenotypes in patients with mutation CD26(G>A)/IVS1-1(G>T), thus indicating other genetic modifiers to be explored in these patients. An increment of 1 % of Hb A level at diagnosis have reduced odds of transfusion dependency by 7% (adjusted OR 0.93,95% CI: 0.90, 0.97; p<0.001) when adjusted for Hb F. Whereas, an increase in 1% of Hb F level, had 1.04 times higher odds to be transfusion dependent (adjusted OR 1.04,95% CI: 1.01, 1.07, p = 0.007) when adjusted for Hb A level. Conclusion: There are diversity of type of β mutation. haematological and clinical parameters among β thalassaemia patients in Kedah. 2020 Thesis http://eprints.usm.my/49359/ http://eprints.usm.my/49359/1/Fahmaa%20Azizi-24%20pages.pdf application/pdf en public masters Universiti Sains Malaysia Pusat Pengajian Sains Perubatan
institution	Universiti Sains Malaysia
collection	USM Institutional Repository
language	English
topic	R Medicine
spellingShingle	R Medicine Azizi, Fahmaa Clinico-haematological profiling of transfusion dependent and non transfucion dependent beta thalassaemia syndrome in Kedah
description	Introduction: β thalassaemia is a group of haemoglobin diseases caused by a reduction or absence in the synthesis of β globin chains. Affected individuals can be heterozygous, compound heterozygous, or homozygous for β thalassaemia, or even have interactions with other haemoglobinopathies. Kedah has a high prevalence of thalassaemia patients with 20.25/100000 populations. Different mutations have been identified in the β globin (HBB) gene generating diverse clinical phenotypes in β thalassaemia. The identification of the genotype is important for proper counselling to patients and their families. Objectives: To determine the clinical, haematology and β mutation profiling of β thalassaemia patients in Kedah. Methods: 100 patients with β thalassaemia were traced through hospital information system. A detailed clinical and laboratory records of patients were retrieved. For β thalassaemia genotyping, 20 different mutations were tested by MARMS technique. Result and Discussions: Out of 100 patients, 66% were transfusion dependent (TDT) and 34% of the studied patients were non transfusion dependent (NTDT). In this study the TDT patients had significantly lower mean age of diagnosis with 2.75 (2.28) years as compared to 19.87(17.87) years in NTDT (p <0.001). There was statistically significant presence of short stature and a larger mean size of spleen in patients with TDT as compared to NTDT. The significant differences between haematological parameters in both groups of patient were well observed in this study. Both NTDT and TDT group of patients were among compound heterozygous Hb E/ β thalassaemia with 85.3% and 75.8% respectively. In TDT patients, the commonest mutations observed was CD26(G>A)/IVS1-5(G>C) (28.8%), followed with CD26(G>A)/IVS1-1(G>T) (13.6%) and CD26(G>A)/CD41/42(-TTCT) (13.6%). In the NTDT group, the common mutations observed were IVS1-1(G>T) and CD19 trans to Hb E (CD26 (G>A) with 32.4% and 29.4%, respectively. It was noted in this study, diversity of phenotypes in patients with mutation CD26(G>A)/IVS1-1(G>T), thus indicating other genetic modifiers to be explored in these patients. An increment of 1 % of Hb A level at diagnosis have reduced odds of transfusion dependency by 7% (adjusted OR 0.93,95% CI: 0.90, 0.97; p<0.001) when adjusted for Hb F. Whereas, an increase in 1% of Hb F level, had 1.04 times higher odds to be transfusion dependent (adjusted OR 1.04,95% CI: 1.01, 1.07, p = 0.007) when adjusted for Hb A level. Conclusion: There are diversity of type of β mutation. haematological and clinical parameters among β thalassaemia patients in Kedah.
format	Thesis
qualification_level	Master's degree
author	Azizi, Fahmaa
author_facet	Azizi, Fahmaa
author_sort	Azizi, Fahmaa
title	Clinico-haematological profiling of transfusion dependent and non transfucion dependent beta thalassaemia syndrome in Kedah
title_short	Clinico-haematological profiling of transfusion dependent and non transfucion dependent beta thalassaemia syndrome in Kedah
title_full	Clinico-haematological profiling of transfusion dependent and non transfucion dependent beta thalassaemia syndrome in Kedah
title_fullStr	Clinico-haematological profiling of transfusion dependent and non transfucion dependent beta thalassaemia syndrome in Kedah
title_full_unstemmed	Clinico-haematological profiling of transfusion dependent and non transfucion dependent beta thalassaemia syndrome in Kedah
title_sort	clinico-haematological profiling of transfusion dependent and non transfucion dependent beta thalassaemia syndrome in kedah
granting_institution	Universiti Sains Malaysia
granting_department	Pusat Pengajian Sains Perubatan
publishDate	2020
url	http://eprints.usm.my/49359/1/Fahmaa%20Azizi-24%20pages.pdf
_version_	1747821993720283136

Clinico-haematological profiling of transfusion dependent and non transfucion dependent beta thalassaemia syndrome in Kedah

Similar Items